Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Necrolytic migratory erythema]

J F Dandrifosse1, A C Dandrifosse, G Piérard

  • 1Service de Biochimie et de Physiologie générale, Université de Liège.

Revue Medicale De Liege
|February 3, 1999
PubMed
Summary

Necrolytic migratory erythema (NME), often linked to glucagonoma, presents a diagnostic challenge due to its fluctuating nature. Treatment involves managing glucagonoma and supportive therapies like amino acids and zinc.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Torsion of the gallbladder: two case reports.

Acta chirurgica Belgica·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007
Same author

[Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].

Revue medicale de Liege·2007
Same author

[Does coffee protect against type 2 diabetes?].

Revue medicale de Liege·2007
Same author

[What about the controversy regarding rosiglitazone].

Revue medicale de Liege·2007
Same author

[Drug of the month. Ezetimibe/simvastatin tablet (Inegy)].

Revue medicale de Liege·2007

Area of Science:

  • Dermatology
  • Endocrinology
  • Oncology

Context:

  • Necrolytic migratory erythema (NME) is a rare skin condition typically associated with glucagonoma, a tumor of the pancreas.
  • NME is characterized by migratory rashes that improve and worsen over time, complicating diagnosis.
  • Understanding the complex etiology of NME is crucial for effective patient management.

Purpose:

  • To elucidate the complex clinical and diagnostic features of Necrolytic migratory erythema (NME).
  • To explore the association between NME and glucagonoma.
  • To review potential therapeutic interventions and etiological hypotheses for NME.

Summary:

  • Necrolytic migratory erythema (NME) diagnosis is complex, often requiring differentiation from other dermatoses.
  • While commonly linked to glucagonoma, NME's fluctuating presentation necessitates careful clinical and microscopic evaluation.
  • Supportive treatments including corticoids, amino acids, zinc, and essential fatty acids can aid management alongside glucagonoma therapy.

Impact:

  • Provides a comprehensive overview of NME, aiding clinicians in diagnosis and treatment planning.
  • Highlights the importance of considering glucagonoma in patients presenting with NME.
  • Contributes to the understanding of NME's pathophysiology and therapeutic options.

Related Experiment Videos